Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

733 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons.
Kelley CF, Acevedo-Quiñones M, Agwu AL, Avihingsanon A, Benson P, Blumenthal J, Brinson C, Brites C, Cahn P, Cantos VD, Clark J, Clement M, Creticos C, Crofoot G, Diaz RS, Doblecki-Lewis S, Gallardo-Cartagena JA, Gaur A, Grinsztejn B, Hassler S, Hinojosa JC, Hodge T, Kaplan R, Lacerda M, LaMarca A, Losso MH, Valdez Madruga J, Mayer KH, Mills A, Mounzer K, Ndlovu N, Novak RM, Perez Rios A, Phanuphak N, Ramgopal M, Ruane PJ, Sánchez J, Santos B, Schine P, Schreibman T, Spencer LY, Van Gerwen OT, Vasconcelos R, Vasquez JG, Zwane Z, Cox S, Deaton C, Ebrahimi R, Wong P, Singh R, Brown LB, Carter CC, Das M, Baeten JM, Ogbuagu O; PURPOSE 2 Study Team. Kelley CF, et al. Among authors: lacerda m. N Engl J Med. 2024 Nov 27. doi: 10.1056/NEJMoa2411858. Online ahead of print. N Engl J Med. 2024. PMID: 39602624
Spatially resolved single-cell atlas unveils a distinct cellular signature of fatal lung COVID-19 in a Malawian population.
Nyirenda J, Hardy OM, Silva Filho JD, Herder V, Attipa C, Ndovi C, Siwombo M, Namalima TR, Suwedi L, Ilia G, Nyasulu W, Ngulube T, Nyirenda D, Mvaya L, Phiri J, Chasweka D, Eneya C, Makwinja C, Phiri C, Ziwoya F, Tembo A, Makwangwala K, Khoswe S, Banda P, Morton B, Hilton O, Lawrence S, Dos Reis MF, Melo GC, de Lacerda MVG, Trindade Maranhão Costa F, Monteiro WM, Ferreira LCL, Johnson C, McGuinness D, Jambo K, Haley M, Kumwenda B, Palmarini M, Denno DM, Voskuijl W, Kamiza SB, Barnes KG, Couper K, Marti M, Otto TD, Moxon CA. Nyirenda J, et al. Among authors: de lacerda mvg. Nat Med. 2024 Nov 20. doi: 10.1038/s41591-024-03354-3. Online ahead of print. Nat Med. 2024. PMID: 39567718
Relative efficacy of anti-Plasmodium vivax malaria combination drugs in preventing transmission to two major Anopheles mosquitos in the first few days of treatment.
Martinez EG, Alencar RM, Santana RAG, Rowena L, Almeida AG, Mwangi VI, Rocha SRDN, de Souza LEB, Silva LM, Pinilla YT, Becker N, Monteiro WM, Lacerda MVG, Secundino TS, Godoy RSM, Rodrigues NB, Secundino NFC, de Melo GC, Pimenta PFP. Martinez EG, et al. Among authors: lacerda mvg. Int J Infect Dis. 2024 Nov 11:107297. doi: 10.1016/j.ijid.2024.107297. Online ahead of print. Int J Infect Dis. 2024. PMID: 39537096 Free article.
Primaquine for uncomplicated Plasmodium vivax malaria in children younger than 15 years: a systematic review and individual patient data meta-analysis.
Commons RJ, Rajasekhar M, Allen EN, Yilma D, Chotsiri P, Abreha T, Adam I, Awab GR, Barber BE, Brasil LW, Chu CS, Cui L, Edler P, Gomes MDSM, Gonzalez-Ceron L, Grigg MJ, Hamid MMA, Hwang J, Karunajeewa H, Lacerda MVG, Ladeia-Andrade S, Leslie T, Longley RJ, Monteiro WM, Pasaribu AP, Poespoprodjo JR, Richmond CL, Rijal KR, Taylor WRJ, Thanh PV, Thriemer K, Vieira JLF, White NJ, Zuluaga-Idarraga LM, Workman LJ, Tarning J, Stepniewska K, Guerin PJ, Simpson JA, Barnes KI, Price RN; WorldWide Antimalarial Resistance Network Paediatric Primaquine Vivax Study Group. Commons RJ, et al. Among authors: lacerda mvg. Lancet Child Adolesc Health. 2024 Nov;8(11):798-808. doi: 10.1016/S2352-4642(24)00210-4. Epub 2024 Sep 24. Lancet Child Adolesc Health. 2024. PMID: 39332427 Free PMC article.
Methaemoglobin as a surrogate marker of primaquine antihypnozoite activity in Plasmodium vivax malaria: A systematic review and individual patient data meta-analysis.
Fadilah I, Commons RJ, Chau NH, Chu CS, Day NPJ, Koh GCKW, Green JA, Lacerda MV, Llanos-Cuentas A, Nelwan EJ, Nosten F, Pasaribu AP, Sutanto I, Taylor WRJ, Thriemer K, Price RN, White NJ, Baird JK, Watson JA. Fadilah I, et al. Among authors: lacerda mv. PLoS Med. 2024 Sep 27;21(9):e1004411. doi: 10.1371/journal.pmed.1004411. eCollection 2024 Sep. PLoS Med. 2024. PMID: 39331646 Free PMC article.
Perception and barriers to access Pre-exposure Prophylaxis for HIV/AIDS (PrEP) among the MSM (men who have sex with men) Brazilian Amazon: A qualitative study.
Batista DR, Dávila RN, Santos ACD, Rocha FQ, Araújo JA, Alencar AC, Nascimento LR, Araújo ND, Lopes SCP, Araújo PS, Filgueiras RA, Saraiva PF, Lacerda MVG, Baía-da-Silva DC, Murta FLG. Batista DR, et al. Among authors: lacerda mvg. PLoS One. 2024 Sep 26;19(9):e0296201. doi: 10.1371/journal.pone.0296201. eCollection 2024. PLoS One. 2024. PMID: 39325811 Free PMC article.
A spatially resolved single-cell lung atlas integrated with clinical and blood signatures distinguishes COVID-19 disease trajectories.
Da Silva Filho J, Herder V, Gibbins MP, Dos Reis MF, Melo GC, Haley MJ, Judice CC, Val FFA, Borba M, Tavella TA, de Sousa Sampaio V, Attipa C, McMonagle F, Wright D, de Lacerda MVG, Costa FTM, Couper KN, Marcelo Monteiro W, de Lima Ferreira LC, Moxon CA, Palmarini M, Marti M. Da Silva Filho J, et al. Among authors: de lacerda mvg. Sci Transl Med. 2024 Sep 11;16(764):eadk9149. doi: 10.1126/scitranslmed.adk9149. Epub 2024 Sep 11. Sci Transl Med. 2024. PMID: 39259811
Antecedent and persistent symptoms in COVID-19 and other respiratory illnesses: Insights from prospectively collected data in the BRACE trial.
McDonald E, Pittet LF, Barry SE, Bonten M, Campbell J, Croda J, Croda MG, Dalcolmo MP, Davidson A, de Almeida E Val FF, Dos Santos G, Gardiner K, Gell G, Gwee A, Krastev A, Lacerda MVG, Lucas M, Lynn DJ, Manning L, McPhate N, Perrett KP, Post JJ, Prat-Aymerich C, Quinn LE, Richmond PC, Wood NJ, Messina NL, Curtis N; BRACE Trial Consortium Group. McDonald E, et al. Among authors: lacerda mvg. J Infect. 2024 Nov;89(5):106267. doi: 10.1016/j.jinf.2024.106267. Epub 2024 Sep 6. J Infect. 2024. PMID: 39245151 Free PMC article. Clinical Trial.
Safety and immunogenicity of a live-attenuated chikungunya virus vaccine in endemic areas of Brazil: interim results of a double-blind, randomised, placebo-controlled phase 3 trial in adolescents.
Buerger V, Hadl S, Schneider M, Schaden M, Hochreiter R, Bitzer A, Kosulin K, Mader R, Zoihsl O, Pfeiffer A, Loch AP, Morandi E Jr, Nogueira ML, de Brito CAA, Croda J, Teixeira MM, Coelho IC, Gurgel R, da Fonseca AJ, de Lacerda MVG, Moreira ED Jr, Veiga APR, Dubischar K, Wressnigg N, Eder-Lingelbach S, Jaramillo JC. Buerger V, et al. Among authors: de lacerda mvg. Lancet Infect Dis. 2024 Sep 4:S1473-3099(24)00458-4. doi: 10.1016/S1473-3099(24)00458-4. Online ahead of print. Lancet Infect Dis. 2024. PMID: 39243794
733 results